# Serological Assay Sensitivity for Feline Leukemia Virus (FeLV) in Progressive vs. Regressive Infections
## Key Takeaways
- Serological sensitivity for Feline Leukemia Virus (FeLV) is critically dependent on the infection outcome; p27 antigen ELISA exhibits high sensitivity (>95%) for progressive infections but significantly lower sensitivity (10-30%) for regressive infections due to transient or absent antigenemia.
- Polymerase Chain Reaction (PCR) assays, particularly quantitative PCR (qPCR) or digital PCR (dPCR), offer superior sensitivity (>90%) for detecting FeLV proviral DNA in both progressive and regressive infections, with dPCR being crucial for low proviral loads in regressive cases.
- Progressive FeLV infections are characterized by sustained high p27 antigenemia and high proviral loads, whereas regressive infections involve transient antigenemia and low-level proviral DNA integration that may remain latent.
- The diagnostic window for p27 ELISA in progressive infection opens around week 2 and persists, while in regressive infection, the window closes after antigen clearance; PCR detects proviral DNA earlier and for a longer duration in both outcomes.
- Relying solely on p27 ELISA for FeLV screening can lead to underestimation of true prevalence by missing regressive infections, necessitating a combined antigen and PCR testing strategy for accurate diagnosis and population health assessment.
---
Feline leukemia virus (FeLV) is a gammaretrovirus that causes persistent infection in domestic cats with two major outcomes: progressive infection and regressive infection [1]. The host-virus interaction determines which outcome occurs, and that outcome directly governs the diagnostic performance of serological assays, particularly those targeting the viral core protein p27 [1]. This article examines the sensitivity of enzyme-linked immunosorbent assay (ELISA)-based p27 antigen detection relative to polymerase chain reaction (PCR)-based detection of proviral DNA in the context of progressive versus regressive FeLV infection.
## FeLV Infection Outcomes and Their Diagnostic Implications
After oronasal exposure, FeLV replicates locally in lymphoid tissue and then spreads systemically. A cat may either control the infection (regressive) or develop persistent viremia (progressive) [1]. Progressive infection is characterized by sustained antigenemia and high proviral loads in blood and tissues. Regressive infection is marked by transient or undetectable antigenemia and low-level proviral DNA integration that may remain latent [1]. The distinction is critical for diagnosis: p27 antigen tests detect free viral capsid protein in plasma, serum, or whole blood, whereas PCR assays detect integrated proviral DNA in host cells [1].
## p27 Antigen Detection by ELISA
The [Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus: p27 Antigen Detection and Diagnostic Interpretation](/knowledge/diagnostics/serology-immunology/elisa-for-feline-leukemia-virus) is the most widely used serological screening method. The assay relies on monoclonal or polyclonal antibodies that capture p27 protein, followed by detection with an enzyme-conjugated antibody [1]. Sensitivity is defined as the proportion of truly infected cats that test positive.
**In progressive infection**, p27 antigen levels are consistently high due to active viral replication. ELISA sensitivity approaches 100% in viremic cats [1]. The diagnostic window begins approximately 2 to 4 weeks post-exposure, when p27 becomes detectable in blood [1]. Once established, antigenemia persists for the lifetime of the cat unless antiviral treatment is administered.
**In regressive infection**, p27 antigenemia is transient. After initial replication, the immune system suppresses viral replication, and p27 becomes undetectable in blood within weeks to months [1]. ELISA often yields false-negative results in regressive cats because p27 is absent from circulation. Sensitivity in this group is low, reported as 10% to 30% in some studies [1]. These cats harbor proviral DNA and can transmit infection under certain conditions, but they are missed by antigen testing alone.
## Limitations of p27 ELISA in Regressive Infection
The main limitation is the absence of p27 during the latent phase. Regressive cats may have undetectable antigen but carry integrated provirus in bone marrow and lymphocytes [1]. Clinical signs may be absent, and the cat appears healthy. ELISA-based screening programs that rely solely on p27 detection will misclassify these cats as negative [1].
Another limitation is the window period. Early after exposure, before p27 reaches detectable levels, ELISA sensitivity is low regardless of eventual outcome [1]. In progressive infection, the window is short (1 to 2 weeks). In regressive infection, the window may be similarly short, but after clearance the cat becomes permanently antigen-negative [1].
## PCR and Proviral DNA Detection
Polymerase chain reaction assays targeting proviral DNA overcome the sensitivity gap in regressive infection. PCR amplifies integrated viral sequences from nucleated blood cells [1]. Proviral DNA is present in both progressive and regressive cats, though at different levels [1].
Quantitative PCR (qPCR) can differentiate between progressive and regressive infection based on proviral load. Progressive cats typically have high proviral loads (greater than 1,000 copies per million cells), whereas regressive cats have low loads (fewer than 100 copies per million cells) [1]. This distinction is clinically useful for prognosis and management.
The diagnostic window for PCR is narrower than for ELISA. Proviral DNA becomes detectable within days post-exposure, often before p27 antigen [1]. However, in regressive infection the low proviral load may fall below the limit of detection of some conventional PCR assays. [Digital PCR for Absolute Quantification of Feline Leukemia Virus Proviral Load](/knowledge/diagnostics/molecular/digital-pcr-absolute-quantification-feline-leukemia-virus-proviral-load) offers improved sensitivity by partitioning the sample into thousands of individual reactions, enabling absolute quantification even at very low copy numbers [1].
## Comparative Sensitivity: ELISA vs. qPCR
| Infection Outcome | p27 ELISA Sensitivity | qPCR/Proviral PCR Sensitivity |
|, - |, - |, - |
| Progressive | >95% (chronic viremia) | >99% |
| Regressive | 10-30% (transient or absent antigen) | >90% (low proviral load may require dPCR) |
| Early acute (both outcomes) | <50% (before antigen peak) | >90% (DNA detectable earlier) |
Table 1. Approximate sensitivity ranges for p27 ELISA and PCR-based assays in different FeLV infection states [1].
The table shows that PCR is superior in regressive and early acute infections. ELISA is adequate only for detecting chronic progressive viremia.
## Clinical Diagnostic Decision Workflow
The diagram below illustrates a recommended testing algorithm.
```mermaid
flowchart TD
A["Cat suspected of FeLV exposure"] --> B{"Perform p27 ELISA"}
B -->|"Positive"| C["Antigen-positive: likely progressive infection"]
B -->|"Negative"| D{"High suspicion or regressive infection?"}
D -->|"No"| E["Negative result, no further testing"]
D -->|"Yes"| F["Perform qPCR or digital PCR for proviral DNA"]
F --> G{"Proviral DNA detected?"}
G -->|"Yes, high load"| H["Progressive infection"]
G -->|"Yes, low load"| I["Regressive infection"]
G -->|"No"| J["False negative likely? Consider repeat PCR"]
```
The algorithm underscores the need for PCR confirmation in antigen-negative cats with risk factors such as known exposure, multicat households, or clinical signs suggestive of retroviral infection [1].
## Diagnostic Window Considerations
The **diagnostic window** is the period during which a test yields a positive result in an infected animal. For p27 ELISA in progressive infection, the window opens around week 2 and remains open indefinitely. In regressive infection, the window closes after p27 clearance, typically within 4 to 8 weeks [1]. PCR opens the window earlier and keeps it open indefinitely in both outcomes, provided proviral DNA persists. However, proviral DNA can become undetectable in some regressive cats after long latency, especially if the provirus is lost from circulating cells [1].
## Implications for Population Screening
In shelter or high-prevalence populations, p27 ELISA alone underestimates true prevalence because regressive infections are missed [1]. Seroprevalence surveys that rely on antigen testing report only the proportion of progressive infections. Adding PCR increases detection of regressive infections and provides a more complete epidemiologic picture [1].
From a clinical management perspective, regressive cats have a better prognosis and lower transmission risk. However, they can still shed virus under immunosuppressive conditions [1]. Correct identification allows appropriate counseling.
## Cross-References
For further reading, see the following articles on this portal:
- [Feline Leukemia Virus Progressive Infection](/knowledge/viruses/pet-viruses/feline-leukemia-virus-progressive-infection)
- [Digital PCR for Absolute Quantification of Feline Leukemia Virus Proviral Load](/knowledge/diagnostics/molecular/digital-pcr-absolute-quantification-feline-leukemia-virus-proviral-load)
- [SNAP Tests versus Reference Lab ELISA for Feline Retrovirus Screening](/knowledge/diagnostics/serology/snap-tests-versus-reference-lab-elisa-for-feline-retrovirus-screening)
- [Loop-mediated Isothermal Amplification (LAMP) for Point-of-Care Detection of Feline Immunodeficiency Virus (FIV) in Blood Samples](/knowledge/diagnostics/molecular/lamp-point-of-care-detection-feline-immunodeficiency-virus)
## Summary
Serological assay sensitivity for FeLV is heavily dependent on infection outcome. p27 ELISA detects progressive infections with high sensitivity but fails in most regressive infections. PCR-based detection of proviral DNA provides superior sensitivity across both outcomes and enables differentiation based on proviral load. Clinicians should use a combination of antigen testing and PCR to avoid misdiagnosis, particularly in cats with regressive infection.
## References
[1] Merck Veterinary Manual. Feline Leukemia Virus Infection. 11th edition. Merck Sharp & Dohme Corp.; 2016.
## Related Clinical & Scientific Guides
* [Loop-Mediated Isothermal Amplification (LAMP) Assay for Rapid Detection of African Swine Fever Virus in Oral Fluids](/knowledge/diagnostics/molecular/lamp-assay-rapid-detection-african-swine-fever-virus-oral-fluids)
* [How to Calculate the Concentration of Protein Using the Lowry Assay](/knowledge/diagnostics/molecular/calculate-protein-concentration-lowry-assay)
* [DNA Extraction from Saliva: Non-Invasive Sampling and Protocols](/knowledge/diagnostics/molecular/dna-extraction-saliva-non-invasive-sampling-protocols)